Celldex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CEOAnthony S. Marucci
CEOAnthony S. Marucci
Employees186
Employees186
HeadquartersHampton, New Jersey
HeadquartersHampton, New Jersey
Founded1983
Founded1983
Employees186
Employees186
CLDX Key Statistics
Market cap1.80B
Market cap1.80B
Price-Earnings ratio-9.00
Price-Earnings ratio-9.00
Dividend yield—
Dividend yield—
Average volume704.78K
Average volume704.78K
High today$27.65
High today$27.65
Low today$26.80
Low today$26.80
Open price$27.24
Open price$27.24
Volume507.05K
Volume507.05K
52 Week high$29.05
52 Week high$29.05
52 Week low$14.40
52 Week low$14.40
CLDX News
Simply Wall St 5d
Celldex Therapeutics: Evaluating Valuation After Barclays’ Cautious Coverage and Renewed Safety ConcernsBarclays has just initiated coverage of Celldex Therapeutics (CLDX), taking a cautious view on the stock because of ongoing safety concerns and a competitive la...
Analyst ratings
81%
of 16 ratingsBuy
81.3%
Hold
12.5%
Sell
6.3%
People also own
Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.